GLP-1 (Glucagon-like peptide-1) injections are a class of medications that mimic the action of the natural GLP-1 hormone in the body, stimulating insulin secretion, suppressing appetite, and delaying gastric emptying, thereby promoting weight loss
Far along in research and development is Eli Lillys retatrutide, a triple agonist that adds glucagon to GLP-1 and GIP, and the requisite studies are underway.1,14 In addition, theres cagrisema from NovoNordisk, a blend of semaglutide (GLP-1 agonist) and a long-acting amylin (another pancreatic hormone) analog cargrilintide
Can semaglutide cause early menopause
However, the modest effect does not negate the potential value of these drugs, especially for conditions where few effective treatment options exist, for example, dementia, Al-Aly said
This project will use an emulated trial design to see if starting GLP-1/GIP drugs actually leads to fewer heart problems, especially in communities with more health disparities
